MaxCyte, Inc.
MXCT
$1.52
-$0.05-3.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -19.72% | -18.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -19.72% | -18.12% | |||
| Cost of Revenue | 5.07% | 1.47% | |||
| Gross Profit | -25.11% | -21.42% | |||
| SG&A Expenses | -28.14% | -2.52% | |||
| Depreciation & Amortization | -3.33% | 1.79% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.18% | 0.22% | |||
| Operating Income | 22.04% | -15.71% | |||
| Income Before Tax | -0.48% | -20.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.48% | -20.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.48% | -20.43% | |||
| EBIT | 22.04% | -15.71% | |||
| EBITDA | 23.69% | -17.32% | |||
| EPS Basic | -0.34% | -19.94% | |||
| Normalized Basic EPS | 24.38% | -20.00% | |||
| EPS Diluted | -0.34% | -19.94% | |||
| Normalized Diluted EPS | 24.38% | -20.00% | |||
| Average Basic Shares Outstanding | 0.20% | 0.43% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||